| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | navitoclax:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.072 | 0.04 |
| mRNA | staurosporine | CTRPv2 | pan-cancer | AAC | 0.15 | 0.04 |
| mRNA | BRD-K49290616 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.04 |
| mRNA | AICAR | GDSC1000 | pan-cancer | AAC | 0.07 | 0.04 |
| mRNA | rTRAIL | GDSC1000 | pan-cancer | AAC | 0.075 | 0.05 |
| mRNA | ouabain | CTRPv2 | pan-cancer | AAC | -0.072 | 0.05 |
| mRNA | SB 216763 | GDSC1000 | pan-cancer | AAC | 0.08 | 0.05 |
| mRNA | WZ-1-84 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.05 |
| mRNA | SB-525334 | CTRPv2 | pan-cancer | AAC | -0.075 | 0.05 |
| mRNA | CR-1-31B | CTRPv2 | pan-cancer | AAC | -0.066 | 0.05 |